Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
nonsteroidal anti-inflammatory drug
|
| gptkbp:approvedBy |
gptkb:Japan
|
| gptkbp:ATCCode |
gptkb:S01BC11
|
| gptkbp:brand |
gptkb:Prolensa
gptkb:BromSite Xibrom |
| gptkbp:CASNumber |
91714-93-1
|
| gptkbp:chemicalFormula |
C15H12BrNO3
|
| gptkbp:contraindication |
hypersensitivity to NSAIDs
|
| gptkbp:discoveredBy |
Senju Pharmaceutical
|
| gptkbp:eliminationHalfLife |
1.4 hours (ocular)
|
| gptkbp:first_approved_year |
2000
|
| https://www.w3.org/2000/01/rdf-schema#label |
bromfenac
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
COX inhibitor
|
| gptkbp:molecularWeight |
334.17 g/mol
|
| gptkbp:pregnancyCategory |
C
|
| gptkbp:routeOfAdministration |
ophthalmic
|
| gptkbp:sideEffect |
blurred vision
eye pain eye irritation |
| gptkbp:usedFor |
postoperative pain in eye surgery
treatment of ocular inflammation |
| gptkbp:bfsParent |
gptkb:Prolensa
gptkb:BromSite |
| gptkbp:bfsLayer |
7
|